Vol. 6, Issue 1, Part A (2024)

Quinoxaline compounds were identified and synthesized based on biological data from multiple critical therapeutic scaffolds accessible from various medicinal chemistry sources. In a single of the current logical research, substituted phenyl-3-hydrazinyl-quinoxaline-2-amines were synthesized, characterized thoroughly by using a few sophisticated spectroscopic instruments which included FT-IR spectroscopy, Mass spectroscopy, and 1H-NMR spectroscopy, along with the CHN Analyzer, and subsequently evaluated for its anti-bacterial potentials against gram-negative microbes (Escherichia coli) and gram-positive microbial organisms (Staphylococcus aureus) using the conventional procedure. Sophisticated spectroscopic tools accurately identified the chemistry and structure of the suggested molecule. In an in-vitro anti-microbial screening assay, the chemical demonstrated amazing antibacterial activity against E. coli and fair bacterial activity against S. aureus, albeit with extremely low concentration. The chemical has been demonstrated to be more efficient against Gram-negative organisms. The research revealed multiple possibilities for the development of broad-spectrum antimicrobial medicines against resistant pathogenic strains by probing into an unknown family of quinoxaline compounds.